电子处方市场－全球产业规模、份额、趋势、机会和预测，按产品（解决方案）、服务、专业领域、给药方式、药物成分、地区和竞争格局划分，2020-2030年预测

2024年全球电子处方市场规模为29.4亿美元，预计到2030年将以8.39%的复合年增长率增长至47.7亿美元。电子处方是指以电子方式产生、传输和执行医疗处方，取代传统的纸本处方方式，从而提高效率和病人安全。推动市场扩张的主要因素包括：整合电子健康记录解决方案的日益普及、政府推广数位医疗的倡议，以及减少用药错误和打击管制药物滥用的迫切需求。

主要市场驱动因素

整合式电子健康记录 (EHR) 系统的日益普及，透过建立处方工作流程的数位基础设施，从根本上推动了全球电子处方市场的发展。当电子处方功能嵌入到全面的 EHR 平台中时，医疗服务提供者可以存取患者病史、过敏资讯和用药清单，从而实现更明智、更安全的处方。

主要市场挑战

阻碍全球电子处方市场扩张的一大挑战是互通性这一长期存在的问题。不同的电子健康记录和药房系统往往缺乏无缝通讯能力，导致患者资料分散，效率低。

主要市场趋势

市场正见证着人工智慧驱动的临床决策支援系统整合的显着趋势，这些系统正超越传统的基于规则的警报，嵌入复杂的人工智慧和机器学习功能。这些先进系统旨在分析大量的患者资料，包括完整的病史、基因组资讯和即时生物特征数据，从而产生高度个人化的治疗建议。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球电子处方市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（解决方案、服务）分类
  • 按专科（肿瘤科、运动医学科、神经科、心臟科、其他）
  • 依交付方式（基于 Web/云端、本机部署）
  • 依物质分类（管制物质、非管制物质）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美电子处方市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲电子处方市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区电子处方市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲电子处方市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美电子处方市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球电子处方市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Oracle Corporation
• Veradigm LLC
• Epic Systems Corporation
• Athenahealth, Inc.
• NextGen Healthcare, Inc.
• McKesson Corporation
• Surescripts, LLC
• Change Healthcare LLC
• Practice Fusion, Inc.
• Networking Technology, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global E-Prescribing Market, valued at USD 2.94 Billion in 2024, is projected to experience a CAGR of 8.39% to reach USD 4.77 Billion by 2030. E-prescribing refers to the electronic generation, transmission, and fulfillment of medical prescriptions, replacing traditional paper-based methods to enhance efficiency and patient safety. The market's expansion is fundamentally driven by the increasing adoption of integrated electronic health record solutions, governmental initiatives promoting digital health, and a critical need to mitigate medication errors and combat controlled substance abuse.

Key Market Drivers

The increasing adoption of integrated Electronic Health Record (EHR) systems fundamentally drives the global e-prescribing market by establishing a digital infrastructure for prescription workflows. When e-prescribing is embedded within comprehensive EHR platforms, healthcare providers access patient histories, allergy information, and medication lists, enabling informed and safer prescribing. This integration boosts clinical efficiency and care coordination, streamlining the entire medication management process.

Key Market Challenges

A significant challenge impeding the global e-prescribing market expansion is the persistent issue of interoperability. Disparate electronic health record and pharmacy systems frequently lack seamless communication capabilities, resulting in fragmented patient data and substantial inefficiencies. This fragmentation creates data silos, preventing comprehensive patient information exchange necessary for accurate and safe medication management across the healthcare continuum.

Key Market Trends

The market is observing a significant trend in the integration of AI-powered clinical decision support systems, moving beyond conventional rule-based alerts to embed sophisticated artificial intelligence and machine learning capabilities. These advanced systems are engineered to analyze extensive patient data, including comprehensive medical histories, genomic information, and real-time biometric inputs, to generate highly personalized treatment recommendations. This enables prescribers to anticipate potential drug interactions with enhanced accuracy, identify subtle disease progression patterns, and tailor medication regimens precisely to individual patient needs. The integration of such intelligent tools signifies a fundamental shift towards a more proactive and data-driven approach to patient care, where decision support is not merely reactive but predictive.

Key Market Players

• Oracle Corporation
• Veradigm LLC
• Epic Systems Corporation
• Athenahealth, Inc.
• NextGen Healthcare, Inc.
• McKesson Corporation
• Surescripts, LLC
• Change Healthcare LLC
• Practice Fusion, Inc.
• Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescribing Market, By Product:

• Solutions
• Services

E-Prescribing Market, By Specialties:

• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

E-Prescribing Market, By Delivery Mode:

• Web/Cloud Based
• On Premise

E-Prescribing Market, By Substances:

• Controlled Substances
• Non-controlled Substances

E-Prescribing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global E-Prescribing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Solutions, Services)
  • 5.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
  • 5.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
  • 5.2.4. By Substances (Controlled Substances, Non-controlled Substances)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America E-Prescribing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Specialties
  • 6.2.3. By Delivery Mode
  • 6.2.4. By Substances
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States E-Prescribing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Specialties
      • 6.3.1.2.3. By Delivery Mode
      • 6.3.1.2.4. By Substances
  • 6.3.2. Canada E-Prescribing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Specialties
      • 6.3.2.2.3. By Delivery Mode
      • 6.3.2.2.4. By Substances
  • 6.3.3. Mexico E-Prescribing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Specialties
      • 6.3.3.2.3. By Delivery Mode
      • 6.3.3.2.4. By Substances

7. Europe E-Prescribing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Specialties
  • 7.2.3. By Delivery Mode
  • 7.2.4. By Substances
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany E-Prescribing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Specialties
      • 7.3.1.2.3. By Delivery Mode
      • 7.3.1.2.4. By Substances
  • 7.3.2. France E-Prescribing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Specialties
      • 7.3.2.2.3. By Delivery Mode
      • 7.3.2.2.4. By Substances
  • 7.3.3. United Kingdom E-Prescribing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Specialties
      • 7.3.3.2.3. By Delivery Mode
      • 7.3.3.2.4. By Substances
  • 7.3.4. Italy E-Prescribing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Specialties
      • 7.3.4.2.3. By Delivery Mode
      • 7.3.4.2.4. By Substances
  • 7.3.5. Spain E-Prescribing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Specialties
      • 7.3.5.2.3. By Delivery Mode
      • 7.3.5.2.4. By Substances

8. Asia Pacific E-Prescribing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Specialties
  • 8.2.3. By Delivery Mode
  • 8.2.4. By Substances
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China E-Prescribing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Specialties
      • 8.3.1.2.3. By Delivery Mode
      • 8.3.1.2.4. By Substances
  • 8.3.2. India E-Prescribing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Specialties
      • 8.3.2.2.3. By Delivery Mode
      • 8.3.2.2.4. By Substances
  • 8.3.3. Japan E-Prescribing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Specialties
      • 8.3.3.2.3. By Delivery Mode
      • 8.3.3.2.4. By Substances
  • 8.3.4. South Korea E-Prescribing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Specialties
      • 8.3.4.2.3. By Delivery Mode
      • 8.3.4.2.4. By Substances
  • 8.3.5. Australia E-Prescribing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Specialties
      • 8.3.5.2.3. By Delivery Mode
      • 8.3.5.2.4. By Substances

9. Middle East & Africa E-Prescribing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Specialties
  • 9.2.3. By Delivery Mode
  • 9.2.4. By Substances
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia E-Prescribing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Specialties
      • 9.3.1.2.3. By Delivery Mode
      • 9.3.1.2.4. By Substances
  • 9.3.2. UAE E-Prescribing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Specialties
      • 9.3.2.2.3. By Delivery Mode
      • 9.3.2.2.4. By Substances
  • 9.3.3. South Africa E-Prescribing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Specialties
      • 9.3.3.2.3. By Delivery Mode
      • 9.3.3.2.4. By Substances

10. South America E-Prescribing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Specialties
  • 10.2.3. By Delivery Mode
  • 10.2.4. By Substances
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil E-Prescribing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Specialties
      • 10.3.1.2.3. By Delivery Mode
      • 10.3.1.2.4. By Substances
  • 10.3.2. Colombia E-Prescribing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Specialties
      • 10.3.2.2.3. By Delivery Mode
      • 10.3.2.2.4. By Substances
  • 10.3.3. Argentina E-Prescribing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Specialties
      • 10.3.3.2.3. By Delivery Mode
      • 10.3.3.2.4. By Substances

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global E-Prescribing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Oracle Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Veradigm LLC
• 15.3. Epic Systems Corporation
• 15.4. Athenahealth, Inc.
• 15.5. NextGen Healthcare, Inc.
• 15.6. McKesson Corporation
• 15.7. Surescripts, LLC
• 15.8. Change Healthcare LLC
• 15.9. Practice Fusion, Inc.
• 15.10. Networking Technology, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer